86 related articles for article (PubMed ID: 7298155)
1. The use of combustion technique of tissue processing for the study of the distribution of 14C-salicylate in rats after oral administration.
Saran-Kumar KV
Indian J Physiol Pharmacol; 1981; 25(3):285-8. PubMed ID: 7298155
[TBL] [Abstract][Full Text] [Related]
2. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
3. Disposition of low doses of 14C-bisphenol A in male, female, pregnant, fetal, and neonatal rats.
Kurebayashi H; Nagatsuka S; Nemoto H; Noguchi H; Ohno Y
Arch Toxicol; 2005 May; 79(5):243-52. PubMed ID: 15902421
[TBL] [Abstract][Full Text] [Related]
4. The dynamics of distribution and excretion of butyl-(2,3-14C)-acrylate in male Wistar albino rats.
Sapota A
Pol J Occup Med Environ Health; 1991; 4(1):55-66. PubMed ID: 1818646
[TBL] [Abstract][Full Text] [Related]
5. Effect of ciprofloxacin on the disposition of 14C-dideoxyinosine-derived radioactivity in the rat.
Gallicano KD; Buttar HS; Moffatt JH
Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):163-74. PubMed ID: 8321920
[TBL] [Abstract][Full Text] [Related]
6. Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats.
Cossum PA; Sasmor H; Dellinger D; Truong L; Cummins L; Owens SR; Markham PM; Shea JP; Crooke S
J Pharmacol Exp Ther; 1993 Dec; 267(3):1181-90. PubMed ID: 8166890
[TBL] [Abstract][Full Text] [Related]
7. Comparative assessment of ocular tissue distribution of drug-related radioactivity after chronic oral administration of 14C-levofloxacin and 14C-chloroquine in pigmented rats.
Tanaka M; Takashina H; Tsutsumi S
J Pharm Pharmacol; 2004 Aug; 56(8):977-83. PubMed ID: 15285841
[TBL] [Abstract][Full Text] [Related]
8. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
9. Absorption, distribution and excretion of 14C-levofloxacin after single oral administration in albino and pigmented rats: binding characteristics of levofloxacin-related radioactivity to melanin in vivo.
Tanaka M; Ono C; Yamada M
J Pharm Pharmacol; 2004 Apr; 56(4):463-9. PubMed ID: 15099441
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats.
Cossum PA; Truong L; Owens SR; Markham PM; Shea JP; Crooke ST
J Pharmacol Exp Ther; 1994 Apr; 269(1):89-94. PubMed ID: 8169856
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of [14C]acetylisoniazid and [14C]acetylhydrazine by the rat and rabbit.
Thomas BH; Whitehouse LW; Zeitz W
Fundam Appl Toxicol; 1984 Aug; 4(4):646-53. PubMed ID: 6479511
[TBL] [Abstract][Full Text] [Related]
12. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and metabolic disposition of 14C-centperazine in rats.
Agarwal N; Agrawal VK; Sharma S; Srivastava VM
Pharmazie; 1987 May; 42(5):332-4. PubMed ID: 3671446
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetic characteristics of salicylates in old animals].
Bezverkhaia IS
Farmakol Toksikol; 1979; 42(5):518-23. PubMed ID: 488327
[TBL] [Abstract][Full Text] [Related]
15. Uptake, distribution, and elimination of carbon tetrachloride in rat tissues following inhalation and ingestion exposures.
Sanzgiri UY; Srivatsan V; Muralidhara S; Dallas CE; Bruckner JV
Toxicol Appl Pharmacol; 1997 Mar; 143(1):120-9. PubMed ID: 9073600
[TBL] [Abstract][Full Text] [Related]
16. Disposition of the opioid antagonist, LY255582, in rats and dogs.
Swanson SP; Catlow J; Pohland RC; Chay SH; Johnson T
Drug Metab Dispos; 1995 Sep; 23(9):916-21. PubMed ID: 8565781
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of NS-105, a novel cognition enhancer. 2nd communication: distribution and transfer into fetus and milk after single administration, and effects of repeated administration on pharmacokinetics and hepatic drug-metabolizing enzyme activities in rats.
Mukai H; Sugimoto T; Ago M; Morino A; Takaichi M; Ogawa Y; Seki H; Matsuura C; Esumi Y
Arzneimittelforschung; 1999 Dec; 49(12):977-85. PubMed ID: 10635441
[TBL] [Abstract][Full Text] [Related]
18. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 3rd communication: placental transfer and excretion into milk in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Feb; 47(2):201-8. PubMed ID: 9079241
[TBL] [Abstract][Full Text] [Related]
19. Uptake of doubly-labelled phosphorylserine in rat brain and intestinal mucosa in vivo.
Palmerini CA; De Medio GE; Porcellati G
Farmaco Sci; 1982 Jan; 37(1):13-21. PubMed ID: 6799325
[TBL] [Abstract][Full Text] [Related]
20. Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats.
Timchalk C; Smith FA; Bartels MJ
Toxicol Appl Pharmacol; 1994 Feb; 124(2):181-90. PubMed ID: 8122263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]